Ingredient
Octoxynol-9
Octoxynol-9 is flagged for pregnancy, breastfeeding, trying to conceive, PCOS, postpartum and general use. The concern behind the strongest flag is endocrine disruptor and fetal development.
- Polyethylene Glycol Octyl Phenyl Ether
- PEG Octylphenyl Ether
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 6 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Octoxynol-9 and pregnancy
Not Recommended
- Endocrine disruptor
- Fetal development
Octoxynol-9 is a surfactant and emulsifier that belongs to the alkylphenol ethoxylate family. These compounds are used in cosmetics to help blend oil and water-based ingredients, improve product texture, and enhance cleansing properties. The primary concern during pregnancy is octoxynol-9's potential endocrine-disrupting activity. According to research reviewed by ECHA, alkylphenol ethoxylates can break down into metabolites like octylphenol, which has demonstrated estrogenic activity in animal studies. While human pregnancy data is limited, the SCCS notes that hormonal disruption during pregnancy could theoretically affect fetal development, particularly reproductive system development. Topical absorption of these compounds has been documented, raising concerns about systemic exposure. Most obstetricians and dermatologists recommend avoiding alkylphenol ethoxylates during pregnancy as a precautionary measure due to their endocrine-disrupting potential. While the EU permits octoxynol-9 in cosmetics, the broader regulatory trend is toward restricting these compounds. Women who are pregnant may wish to choose products with alternative, non-endocrine disrupting surfactants.
Octoxynol-9 and breastfeeding
Not Recommended
- Endocrine disruptor
- Passes into breast milk
Octoxynol-9 and its alkylphenol ethoxylate relatives have lipophilic (fat-loving) properties that raise theoretical concerns about transfer into breast milk, which has a high fat content. While specific studies on octoxynol-9 in breast milk are not available, related compounds in this chemical family have been detected in biological tissues. The concern for breastfeeding relates to potential endocrine disruption in breastfed infants. The AAD and most dermatologists note that infants are particularly vulnerable to hormone-disrupting chemicals during early development. Given the estrogenic activity of octoxynol-9's breakdown products and the uncertainty about milk transfer, many experts recommend caution. While definitive evidence of harm is lacking, the precautionary principle suggests avoiding alkylphenol ethoxylates while breastfeeding. Safer surfactant alternatives are widely available in modern cosmetic formulations.
Octoxynol-9 and postpartum
Caution Advised
- Endocrine disruptor
For postpartum women not breastfeeding, the primary concern with octoxynol-9 remains its potential endocrine-disrupting properties, though the risk level is lower than during pregnancy or breastfeeding when fetal or infant exposure is a concern. Postpartum hormone regulation is a delicate process, and some women may prefer to avoid ingredients with estrogenic activity during this transitional period. However, the evidence for significant hormonal disruption from topical cosmetic use in non-pregnant, non-breastfeeding adults is limited. Individual sensitivity and preference should guide decisions.
Octoxynol-9 and trying to conceive
Not Recommended
- Hormone disruptor
- Fertility effects
When trying to conceive, minimizing exposure to endocrine disruptors is recommended by reproductive medicine specialists. Octoxynol-9 belongs to a chemical family with documented estrogenic activity, which could theoretically interfere with the delicate hormonal balance required for conception. While direct evidence linking topical octoxynol-9 use to fertility problems is lacking, the precautionary approach favored by most fertility specialists includes avoiding known endocrine disruptors. The compound's ability to break down into more potent estrogenic metabolites is a particular concern during the preconception period when optimizing hormone balance is important.
Octoxynol-9 and PCOS
Not Recommended
- Affects estrogen
- Interferes with hormones
Octoxynol-9 is particularly concerning for women with PCOS due to its endocrine-disrupting properties. PCOS involves complex hormonal imbalances, and exposure to xenoestrogens (environmental estrogens) can potentially worsen hormonal dysregulation. Research published in endocrinology journals suggests that alkylphenol ethoxylates can interfere with both estrogen and androgen pathways. For women with PCOS who already struggle with hormone balance, avoiding additional endocrine disruptors is widely recommended by reproductive endocrinologists. While a single cosmetic product containing octoxynol-9 is unlikely to significantly affect PCOS symptoms, minimizing cumulative exposure to endocrine disruptors is considered good practice. Many PCOS specialists recommend choosing cosmetics free from known hormone disruptors as part of a comprehensive management approach.
Octoxynol-9 and general use
Caution Advised
- Endocrine disruptor
- Irritant
For the general population, octoxynol-9 presents moderate concerns primarily related to its classification as an alkylphenol ethoxylate with potential endocrine-disrupting properties. The SCCS has noted that these compounds can metabolize into more problematic substances with estrogenic activity. Octoxynol-9 can also cause mild to moderate skin irritation in some individuals, particularly in leave-on products or higher concentrations. People with sensitive skin may experience redness, dryness, or irritation from products containing this surfactant. The EU regulatory framework increasingly restricts alkylphenol ethoxylates due to both environmental and health concerns. While octoxynol-9 remains permitted in cosmetics, consumer awareness and preference for alternative surfactants has grown. Many modern formulations use gentler, non-endocrine disrupting alternatives that are equally effective.
Everything else flagged for the same profiles
Related ingredients
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store